Drug:
Reaction: MYELOSUPPRESSION
20250101 - 20251231
No. 401 - 500
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 401 | 25075258 |
CN |
76 | 2 |
Myelosuppression, |
||||
VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 402 | 25075449 |
CN |
48 | 2 |
Myelosuppression, |
||||
| 403 | 25075451 |
CN |
56 | 2 |
Myelosuppression, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 404 | 25075570 |
CN |
68 | 2 |
Myelosuppression, |
||||
DARATUMUMAB, DARATUMUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 405 | 25075686 |
CN |
16 | 2 |
Myelosuppression, |
||||
VENETOCLAX, |
||||
| 406 | 25075859 |
JP |
9 | 2 |
Depressed level of consciousness, Myelosuppression, Infusion related reaction, Blood pressure decreased, Bradycardia, Decreased appetite, Stomatitis, Off label use, |
||||
AMIVANTAMAB, AMIVANTAMAB, AMIVANTAMAB, PACLITAXEL, CARBOPLATIN, PEMETREXED, PEMETREXED DISODIUM, |
||||
| 407 | 25075877 |
CN |
75 | |
Myelosuppression, |
||||
PACLITAXEL, |
||||
| 408 | 25075898 |
CN |
72 | |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, |
||||
| 409 | 25075908 |
CN |
51 | |
Myelosuppression, |
||||
ETOPOSIDE, ETOPOSIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, CARBOPLATIN, |
||||
| 410 | 25075918 |
CN |
66 | |
Myelosuppression, |
||||
| 411 | 25075958 |
CN |
62 | |
Myelosuppression, Platelet count decreased, |
||||
CISPLATIN, PACLITAXEL, |
||||
| 412 | 25075969 |
CN |
66 | |
Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, CAPECITABINE, |
||||
| 413 | 25075977 |
CN |
55 | |
Myelosuppression, |
||||
ETOPOSIDE, CARBOPLATIN, |
||||
| 414 | 25076003 |
CN |
||
Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, CISPLATIN, |
||||
| 415 | 25076011 |
CN |
53 | |
Myelosuppression, Off label use, |
||||
ZANUBRUTINIB, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 416 | 25076027 |
CN |
||
Myelosuppression, |
||||
ETOPOSIDE, CARBOPLATIN, |
||||
| 417 | 25076062 |
CN |
||
Myelosuppression, |
||||
PACLITAXEL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 418 | 25076081 |
CN |
||
Myelosuppression, |
||||
PEMETREXED DISODIUM, PEMETREXED, CISPLATIN, CISPLATIN, |
||||
| 419 | 25076361 |
CN |
80 | 1 |
Myelosuppression, Product prescribing issue, Incorrect dose administered, |
||||
REGORAFENIB, |
||||
| 420 | 25076429 |
CN |
72 | |
Myelosuppression, |
||||
CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, |
||||
| 421 | 25076465 |
CN |
69 | |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL, PACLITAXEL, PACLITAXEL, |
||||
| 422 | 25076484 |
CN |
68 | |
Myelosuppression, |
||||
| 423 | 25076563 |
ES |
1 | |
Myelosuppression, Drug ineffective, Drug interaction, Disease progression, |
||||
MIRTAZAPINE, LINEZOLID, LINEZOLID, LINEZOLID, LINEZOLID, PACLITAXEL, PACLITAXEL, PACLITAXEL, PACLITAXEL, PACLITAXEL, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, VINORELBINE, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, TRIMETHOPRIM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, APIXABAN, ALPRAZOLAM, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, CEFTRIAXONE, CEFTRIAXONE SODIUM, AMIKACIN, |
||||
| 424 | 25076595 |
CA |
76 | 2 |
Anaemia, Myelosuppression, Neutropenia, Pancytopenia, Thrombocytopenia, |
||||
CEDAZURIDINE AND DECITABINE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, LACTULOSE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 425 | 25076821 |
CN |
73 | |
Myelosuppression, Neurotoxicity, |
||||
PACLITAXEL, |
||||
| 426 | 25066055 |
CN |
59 | |
Myelosuppression, |
||||
| 427 | 25066098 |
CN |
60 | |
Myelosuppression, |
||||
CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, |
||||
| 428 | 25066102 |
CN |
64 | |
Myelosuppression, |
||||
CARBOPLATIN, IRINOTECAN HYDROCHLORIDE, |
||||
| 429 | 25066158 |
CN |
51 | |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, |
||||
| 430 | 25066299 |
CN |
65 | 2 |
Myelosuppression, |
||||
BEVACIZUMAB, CARBOPLATIN, PACLITAXEL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 431 | 25066917 |
CN |
56 | 2 |
Myelosuppression, Hepatic function abnormal, |
||||
PERTUZUMAB, TRASTUZUMAB, EPIRUBICIN HYDROCHLORIDE, PACLITAXEL, |
||||
| 432 | 25067151 |
CN |
42 | 1 |
Myelosuppression, Pneumonia, Diarrhoea, |
||||
PRALSETINIB, PRALSETINIB, |
||||
| 433 | 25067299 |
CN |
||
Myelosuppression, |
||||
GOSERELIN, GOSERELIN, GOSERELIN, BICALUTAMIDE, |
||||
| 434 | 25068190 |
CN |
39 | 2 |
Myelosuppression, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 435 | 25068202 |
CN |
61 | 2 |
Myelosuppression, |
||||
| 436 | 25068233 |
CN |
14 | 2 |
Pancreatitis acute, Mouth ulceration, Myelosuppression, Abdominal pain, Nausea, Amylase increased, Lipase increased, Pharyngeal erythema, Erythema, Swelling, Mucosal erosion, Gingival pain, |
||||
CYTARABINE, CYTARABINE, METHOTREXATE SODIUM, DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE, PEGASPARGASE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 437 | 25068633 |
CN |
64 | 1 |
Myelosuppression, White blood cell count decreased, Neutrophil count decreased, Thrombocytopenic purpura, |
||||
CYTARABINE, CYTARABINE, CYTARABINE, IDARUBICIN HYDROCHLORIDE, IDARUBICIN HYDROCHLORIDE, IDARUBICIN HYDROCHLORIDE, |
||||
| 438 | 25068643 |
CN |
33 | 1 |
Haemorrhage, Myelosuppression, |
||||
CYTARABINE, |
||||
| 439 | 25069414 |
CN |
58 | 2 |
Myelosuppression, Product use in unapproved indication, Nausea, Decreased appetite, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, SELINEXOR, OLANZAPINE, PALONOSETRON, PALONOSETRON HYDROCHLORIDE, LENALIDOMIDE, BORTEZOMIB FOR INJECTION, BORTEZOMIB, |
||||
| 440 | 25069415 |
CN |
66 | 1 |
Myelosuppression, Product use in unapproved indication, Pyrexia, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, SELINEXOR, OLANZAPINE, PALONOSETRON, PALONOSETRON HYDROCHLORIDE, LENALIDOMIDE, BORTEZOMIB FOR INJECTION, BORTEZOMIB, |
||||
| 441 | 25069476 |
CN |
63 | 1 |
Myelosuppression, Product use in unapproved indication, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, SELINEXOR, OLANZAPINE, PALONOSETRON, PALONOSETRON HYDROCHLORIDE, LENALIDOMIDE, BORTEZOMIB FOR INJECTION, BORTEZOMIB, |
||||
| 442 | 25069481 |
CN |
55 | 2 |
Myelosuppression, Product use in unapproved indication, Fatigue, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, SELINEXOR, OLANZAPINE, PALONOSETRON, PALONOSETRON HYDROCHLORIDE, LENALIDOMIDE, BORTEZOMIB FOR INJECTION, BORTEZOMIB, |
||||
| 443 | 25069495 |
CN |
68 | 2 |
Myelosuppression, Product use in unapproved indication, Abdominal pain, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, SELINEXOR, OLANZAPINE, PALONOSETRON, PALONOSETRON HYDROCHLORIDE, LENALIDOMIDE, BORTEZOMIB FOR INJECTION, BORTEZOMIB, |
||||
| 444 | 25069569 |
CN |
58 | 2 |
Myelosuppression, Sepsis, Infection, Pyrexia, |
||||
VENETOCLAX, GILTERITINIB, AZACITIDINE, AZACITIDINE FOR, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 445 | 25069725 |
CN |
68 | 1 |
Myelosuppression, |
||||
CETUXIMAB, OXALIPLATIN, |
||||
| 446 | 25069778 |
CN |
50 | |
Myelosuppression, |
||||
OSIMERTINIB, |
||||
| 447 | 25070245 |
CN |
49 | 2 |
Oropharyngeal discomfort, Myelosuppression, Pyrexia, White blood cell count decreased, Oropharyngeal pain, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 448 | 25071268 |
CN |
72 | |
Myelosuppression, |
||||
ZANUBRUTINIB, RITUXIMAB, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 449 | 25071297 |
CN |
||
Death, Feeding disorder, Gastrointestinal disorder, Myelosuppression, Drug ineffective, |
||||
ABEMACICLIB, |
||||
| 450 | 25061363 |
CN |
3 | 2 |
Myelosuppression, |
||||
VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 451 | 25062364 |
CN |
58 | 2 |
Myelosuppression, |
||||
PERTUZUMAB, TRASTUZUMAB, |
||||
| 452 | 25062654 |
CN |
61 | 1 |
Myelosuppression, |
||||
CARFILZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 453 | 25062689 |
CN |
70 | 1 |
Myelosuppression, |
||||
CARFILZOMIB, LENALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, WATER, STERILE WATER, STERILE WATER FOR INJECTION, |
||||
| 454 | 25063057 |
CN |
52 | 2 |
Myelosuppression, Pyrexia, |
||||
PEMETREXED, PEMETREXED DISODIUM, CARBOPLATIN, |
||||
| 455 | 25063425 |
CN |
56 | 1 |
Myelosuppression, White blood cell count decreased, Platelet count decreased, |
||||
CYTARABINE, |
||||
| 456 | 25063515 |
CN |
67 | 1 |
Myelosuppression, Thrombocytopenia, Febrile neutropenia, Diarrhoea, Pyrexia, |
||||
| 457 | 25063659 |
CN |
76 | 1 |
Myelosuppression, |
||||
DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 458 | 25063920 |
CN |
87 | 2 |
Myelosuppression, Pyrexia, |
||||
VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 459 | 25063991 |
CN |
62 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, PERTUZUMAB, |
||||
| 460 | 25064199 |
CN |
||
Myelosuppression, |
||||
PACLITAXEL, |
||||
| 461 | 25064210 |
CN |
||
Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, CISPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 462 | 25064313 |
CN |
46 | |
Myelosuppression, |
||||
FULVESTRANT, FULVESTRANT, PERTUZUMAB, TRASTUZUMAB, |
||||
| 463 | 25064325 |
CN |
40 | |
Myelosuppression, White blood cell count decreased, Anaemia, |
||||
OLAPARIB, |
||||
| 464 | 25064483 |
CN |
30 | 2 |
Myelosuppression, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE, ZANUBRUTINIB, ZANUBRUTINIB, RITUXIMAB, RITUXIMAB, |
||||
| 465 | 25064528 |
CN |
54 | 2 |
Myelosuppression, |
||||
CETUXIMAB, |
||||
| 466 | 25064530 |
CN |
||
Death, Feeding disorder, Gastrointestinal disorder, Myelosuppression, Drug ineffective, |
||||
ABEMACICLIB, |
||||
| 467 | 25064547 |
CN |
55 | 2 |
Myelosuppression, Off label use, |
||||
ABEMACICLIB, |
||||
| 468 | 25064695 |
GB |
||
Neutropenia, Myelosuppression, Osteonecrosis, Osteoarthritis, Fear of injection, Arthralgia, |
||||
CABOTEGRAVIR SODIUM, CABOTEGRAVIR SODIUM, CABOTEGRAVIR SODIUM, |
||||
| 469 | 25064801 |
60 | ||
Myelosuppression, |
||||
RUXOLITINIB, DECITABINE, |
||||
| 470 | 25064821 |
43 | ||
Myelosuppression, |
||||
RUXOLITINIB, ETOPOSIDE, ETOPOSIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, VINCRISTINE SULFATE, VINCRISTINE SULFATE, |
||||
| 471 | 25065144 |
JP |
||
Myelosuppression, |
||||
BORTEZOMIB FOR INJECTION, BORTEZOMIB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 472 | 25065342 |
CN |
75 | |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, |
||||
| 473 | 25056843 |
JP |
73 | 2 |
Myelosuppression, Hypomagnesaemia, Infusion related reaction, Oropharyngeal discomfort, Off label use, |
||||
AMIVANTAMAB, CARBOPLATIN, PEMETREXED, PEMETREXED DISODIUM, BEVACIZUMAB, ATEZOLIZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, RAMUCIRUMAB, |
||||
| 474 | 25056993 |
CN |
63 | 2 |
Myelosuppression, |
||||
BEVACIZUMAB, CARBOPLATIN, PACLITAXEL, |
||||
| 475 | 25058099 |
ES |
||
Pseudomonas infection, Pulmonary sepsis, Drug level increased, Myelosuppression, |
||||
LINEZOLID, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, APIXABAN, ALPRAZOLAM, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, |
||||
| 476 | 25058671 |
JP |
||
Myelosuppression, Pyrexia, |
||||
PEMBROLIZUMAB, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, CISPLATIN, CISPLATIN, |
||||
| 477 | 25059031 |
CN |
80 | 2 |
Myelosuppression, |
||||
BEVACIZUMAB, CAPECITABINE, OXALIPLATIN, |
||||
| 478 | 25059224 |
CN |
||
Myelosuppression, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, CISPLATIN, FLUOROURACIL, |
||||
| 479 | 25060516 |
CN |
78 | 2 |
Myelosuppression, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, DOXORUBICIN, PREDNISONE, PREDNISONE, |
||||
| 480 | 25060672 |
CN |
53 | |
Myelosuppression, |
||||
| 481 | 25060726 |
CN |
59 | 1 |
Myelosuppression, Anaemia, Full blood count decreased, Pneumonia, Rash erythematous, Pruritus, Rash, Dermatitis allergic, Platelet count decreased, |
||||
CYTARABINE, |
||||
| 482 | 25060751 |
CN |
66 | |
Myelosuppression, |
||||
CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, |
||||
| 483 | 25060752 |
JP |
72 | 1 |
Myelosuppression, Neutrophil count decreased, |
||||
PEMBROLIZUMAB, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, CISPLATIN, |
||||
| 484 | 25055897 |
CN |
46 | 2 |
Myelosuppression, |
||||
DENOSUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, TRASTUZUMAB, |
||||
| 485 | 25056088 |
CN |
70 | |
Myelosuppression, |
||||
| 486 | 25056092 |
CN |
62 | |
Myelosuppression, |
||||
PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, |
||||
| 487 | 25056098 |
CN |
71 | |
Myelosuppression, Abdominal infection, |
||||
FLUOROURACIL, FLUOROURACIL, FLUOROURACIL, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, |
||||
| 488 | 25056099 |
CN |
55 | |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 489 | 25056173 |
CN |
62 | |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE, |
||||
| 490 | 25056179 |
CN |
71 | |
Myelosuppression, |
||||
CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 491 | 25056199 |
CN |
77 | |
Myelosuppression, Hypokalaemia, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 492 | 25055316 |
CN |
54 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, |
||||
| 493 | 25055319 |
CN |
45 | 1 |
Myelosuppression, Infection, Respiratory failure, |
||||
CISPLATIN, ETOPOSIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, CISPLATIN, CISPLATIN, CISPLATIN, ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, |
||||
| 494 | 25048291 |
CN |
54 | 2 |
Myelosuppression, |
||||
DARATUMUMAB, DARATUMUMAB, SELINEXOR, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, DEXTROSE MONOHYDRATE, DEXTROSE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 495 | 25048593 |
CN |
46 | 2 |
Myelosuppression, Off label use, |
||||
PERTUZUMAB, TRASTUZUMAB, FULVESTRANT, |
||||
| 496 | 25048799 |
CN |
||
Myelosuppression, |
||||
GOSERELIN, GOSERELIN, GOSERELIN, GOSERELIN, GOSERELIN, GOSERELIN, GOSERELIN, GOSERELIN, DENOSUMAB, TRASTUZUMAB, |
||||
| 497 | 25048821 |
CN |
57 | 2 |
Myelosuppression, |
||||
VENETOCLAX, CYTARABINE, |
||||
| 498 | 25048830 |
CZ |
66 | 1 |
Myelosuppression, Neurotoxicity, |
||||
PREDNISONE, RITUXIMAB, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, ETOPOSIDE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CYTARABINE, CYTARABINE, OXALIPLATIN, |
||||
| 499 | 25049036 |
CN |
59 | 2 |
White blood cell count decreased, Neutrophil count decreased, Platelet count decreased, Myelosuppression, Hypertension, Sinus tachycardia, Coccydynia, Dyschezia, C-reactive protein increased, Rectal cancer, |
||||
BEVACIZUMAB, GEMCITABINE HYDROCHLORIDE, FOLIC ACID, |
||||
| 500 | 25049109 |
JP |
61 | 2 |
Fracture, Myelosuppression, |
||||
PAZOPANIB HYDROCHLORIDE, PAZOPANIB HYDROCHLORIDE, PAZOPANIB HYDROCHLORIDE, PAZOPANIB HYDROCHLORIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28